Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company's Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel – GlobeNewswire

Share Article

| Source: Citrine Global, Corp. Citrine Global, Corp.
ISRAEL
Tel Aviv, May 31, 2022 (GLOBE NEWSWIRE) — Citrine Global Corp. (OTCQB: CTGL) is pleased to announce Prof. Itamar Grotto joining the Board of Directors of the Company’s Israeli subsidiary, Cannovation Center Israel Ltd., Citrine Global’s Advisory Board and appointed as President of Green Vision Center Israel.
Green Vision Center Israel is part of the Company’s strategy to create end-to-end plant-based solutions covering all the infrastructure, facilities, and activities required for developing, manufacturing, and bringing to market innovative plant-based wellness and pharma products. Professor Grotto brings his expertise in the health, pharma and wellness industries and will promote the Company’s strategy to bring to market innovative plant-based wellness and pharma solutions and business collaborations with pharma and wellness companies from all over the world.
The company acquired 125,000 square feet of land (11,687 sqm) in the south of Israel with government support for building the Green Vision Center Israel, which will include manufacturing plants, laboratories, logistics, import and export, offices, training, conference center, and an international visitor complex, providing in a single location everything required for production, innovation, and release-to-market of plant-based wellness & pharma products.

Prof. Grotto said, “I am excited to be part of the Company’s team and be the President of Green Vision Center Israel, a first-of-its-kind production and innovation center for pharma and wellness solutions. I believe that such a center is very much needed, and I will apply my expertise and experience to realize the mission to become a worldwide center and bring to the center collaborations with market leaders and companies from all over the world.”
Ora Elharar Soffer, CEO and Chairman of the Board of Citrine Global said, “We are proud to have Prof. Grotto on our team and we believe that Prof. Grotto’s experience as a world-renowned medical expert will be a significant contribution to realize our mission to bring to market innovative plant-based wellness and pharma solutions that can help improve people’s health and quality of life”.
About Citrine Global Corp.
Citrine Global is a plant-based wellness and pharma solutions company.
The company’s mission is to leverage the power of plant-based solutions from nature to help improve people’s health and quality of life.
The Company is building an end-to-end strategy covering all the infrastructure, facilities, and activities required for developing, manufacturing, and bringing to market plant-based wellness and pharma products.
Citrine Global developed the Green Side by Side product lines targeting to promote wellbeing and complementary products for balancing selected side effects caused by medicines, treatments, or an unbalanced lifestyle. In Q1 2022 the Company launched in the Israeli market several products with plans for worldwide distribution.
Citrine Global acquired 125,000 square feet of land (11,687 sqm) in the south of Israel, backed by the Israeli government support, to build the Green Vision Center Israel, a first-of-its-kind production and innovation center providing in a single location everything required for production, innovation, and release-to-market of plant-based wellness & pharma products.
Citrine Global is a public company traded on the OTCQB and has filed an application with Nasdaq to list the Company’s common stock.
For more information visit our website www.citrine-global.com

Safe Harbor Statement
This press release contains express or implied forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S. federal securities laws. For example, Citrine Global is using forward-looking statements when it discusses that Cannovation Center Israel Ltd. will create an eco-system that will attract partners, market leaders, companies, and technologies, and will turn Cannovation Center Israel Ltd. into a global center in these fields. These forward-looking statements and their implications are based on the current expectations of the management of Citrine Global and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include but are not limited to trends in target markets; effects of competition in the Company’s main markets; ability to establish and maintain strategic relationships in its major businesses, our ability to raise sufficient capital resources to realize our business plan, our ability to successfully uplist to the Nasdaq Stock market, profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and regulatory forces. Our actual results, performance, or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including the risks discussed under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K and in our other filings with the SEC. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, except as required by law.

Attachment

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness